Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool aims to spot wound healing hurdles early

NCT ID NCT07334717

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 19, 2026 · Updated 2 times

Summary

This study is for people with wounds that have developed hypergranulation (overgrown tissue that slows healing). Researchers will take photos and use a new assessment tool to grade the severity. About 100 adults and children in the UK will take part. The goal is to create a standard way to measure hypergranulation, which will help design future treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

3 people

The number who actually took part.

Started

Apr 2026

Finished

Jun 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Approximately 80-100 participants who meet the inclusion criteria will be be recruited into the study. Participants will be recruited from tissue viability clinics, burns clinics and wound care clinics across the North West of England.

Ages

2 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Male or female participants between 2 to 85 years of age (both inclusive). * Willing and able to provide written informed consent or assent (as applicable) as evidenced by signature on the participant's consent/assent form. In case if the child is providing assent, a caregiver or LAR must sign an informed consent. * A chronic HG wound which can be: * a VLU unhealed for a minimum of 6 weeks, but no longer than 24 weeks * an unhealed surgical wound that has been unhealed for at least 2 weeks but no longer than 24 weeks * a device entering the skin (eg, gastrostomy, suprapubic catheter, tracheostomy etc) that exhibits HG. * A degree of HG that is estimated to be raised at least 2 mm above the natural skin level, or above the base of the wound and an area of HG extending at least 10 mm in its longest length. * For VLU and surgical wounds, the wound should not have been healed by at least 25% area or length. * Have good general health as defined by: * medically fit enough to complete the study assessments * free of any other systemic condition that in the opinion of the Study Investigator may have an impact on the safety of the participant. * Be willing and able to attend all scheduled clinical assessments, (adults or caregiver) * able to communicate well with the Study Investigator and willing and able to comply with the expectations of the study. * This includes gastrostomy; suprapubic catheters, tracheostomy, other tube/catheter skin entry or exit sites, abdominal surgical wound, pilonidal sinus surgical site, split-skin donor site, plastic surgery sites, healing burn sites, peri-anal surgical wounds, gastrointestinal stoma, other. Exclusion Criteria * Unable to provide informed consent or assent * Unable to complete the scheduled study treatments and assessments * Have been previously recruited into this study * Participants who are \< 2 years or \>85 years of age

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Venous leg ulcers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • EMS Healthcare

    Ellesmere Port, Cheshire, CH65 4LE, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.